Long
Sinovac Biotech, Ltd.
No trades
No trades
Peers for comparison
−1.37 USD
−59.68 M USD
386.01 M USD
20.59 M
Next report date
Report period
EPS estimate
Revenue estimate
Company info
Sector
Industry
CEO
Wei Dong Yin
Website
Headquarters
Beijing
Founded
1993
IPO date
Nov 13, 2009
ISIN
AGP8696W1045
CUSIP
P8696W104
FIGI
BBG000D0D8P5
Identifiers
ISIN AGP8696W1045
Sinovac Biotech Ltd. is a holding company, which engages in the research, development, manufacture, and commercialization of vaccines that protect against human infectious diseases. Its product portfolio includes vaccines against enterovirus71, or EV71, hepatitis A and B, seasonal influenza, H5N1 pandemic influenza, H1N1 influenza, and mumps. The company was founded in 1993 and is headquartered in Beijing, China.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently asked questions
Today, SVA trades at 6.47 USD.
For broader market analysis, dive into the technicals on the Sinovac Biotech, Ltd. stock price chart and read the latest SVA news:
– Sinovac Biotech Price Target Cut to $1.00/Share From $6.00 by HC Wainwright & Co.
– Vaccine maker Sinovac H1 revenue rises on overseas growth, approvals
– Sinovac Biotech 1H Loss/Shr 84c >SVA
For broader market analysis, dive into the technicals on the Sinovac Biotech, Ltd. stock price chart and read the latest SVA news:
– Sinovac Biotech Price Target Cut to $1.00/Share From $6.00 by HC Wainwright & Co.
– Vaccine maker Sinovac H1 revenue rises on overseas growth, approvals
– Sinovac Biotech 1H Loss/Shr 84c >SVA
Markets don't sleep, here's what's going on with SVA at the moment:
– Sinovac Biotech Price Target Cut to $1.00/Share From $6.00 by HC Wainwright & Co.
– Vaccine maker Sinovac H1 revenue rises on overseas growth, approvals
– Sinovac Biotech 1H Loss/Shr 84c >SVA
See more updates in real-time with our News Flow.
– Sinovac Biotech Price Target Cut to $1.00/Share From $6.00 by HC Wainwright & Co.
– Vaccine maker Sinovac H1 revenue rises on overseas growth, approvals
– Sinovac Biotech 1H Loss/Shr 84c >SVA
See more updates in real-time with our News Flow.
Sinovac Biotech, Ltd. is scheduled to release its next earnings report on May 3, 2027.
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release
How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
Sinovac Biotech, Ltd. market capitalization is 464.94 M, representing the total value of all its outstanding shares (price × shares outstanding).
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Sinovac Biotech, Ltd. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Sinovac Biotech, Ltd. stacks up against other companies
What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements
What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Sinovac Biotech, Ltd. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Sinovac Biotech, Ltd. stacks up against other companies
The safest way to buy Sinovac Biotech, Ltd. stocks is through a reliable broker. Create an account, fund it, and place a buy order.
You can trade SVA directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
You can trade SVA directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart
Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 11, 2026, the company has 2.6 K employees.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements
See our rating of the largest employers to find more opportunities.
Investing in Sinovac Biotech, Ltd. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.
First, study Sinovac Biotech, Ltd. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our SVA technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
First, study Sinovac Biotech, Ltd. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency
Then explore our SVA technicals – signals based on essential indicators calculations:
– Today — sell
– 1-week — sell
– 1-month — sell
Combine fundamental and technical analysis for better results.
Sinovac Biotech, Ltd. stock ticker depends on the exchange where it’s listed. On the NASDAQ, its primary exchange, Sinovac Biotech, Ltd. stocks trade under the symbol SVA.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners
Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion
Learn how to find your desired assets in our Symbol Search.
Yes, you can track Sinovac Biotech, Ltd. financials in yearly and quarterly reports right on TradingView.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
Use our Earnings Calendar to never miss important releases and spot opportunities early.
SVA net income for the last half-year is −60.24 M USD, while the half-year before that showed −38.01 M USD of net income which accounts for −58.46% change.
How to read this data:
– Track changes: Compare net income across periods to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one period: Consistency matters more than a single result
Follow other essential metrics in Sinovac Biotech, Ltd. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
How to read this data:
– Track changes: Compare net income across periods to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one period: Consistency matters more than a single result
Follow other essential metrics in Sinovac Biotech, Ltd. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
SVA reached its all-time high of 12.50 USD on Sep 1, 2009. Its all-time low was 0.75 USD and was reached on Sep 30, 2003.
Explore the Sinovac Biotech, Ltd. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Explore the Sinovac Biotech, Ltd. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Sinovac Biotech, Ltd. EBITDA is −117.10 M USD, with an EBITDA margin of −48.61%.
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Sinovac Biotech, Ltd. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality
EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.
What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures
What to look at next in Sinovac Biotech, Ltd. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality